Metabolic associations with genes known to associate with bladder cancer (BLCAP), ovarian cancer (OCIAD1), and infertility caused by azoospermia (DAZAP1) could highlight the importance of integrating both methylation and metabolomics for assessing T2D complications. The gene discussed is OCIAD1; the disease is ovarian cancer.